Effect of Selepressin vs Placebo on Ventilator- and Vasopressor-Free Days in Patients With Septic ShockPierre‐François Laterre, Todd Graves, Karsten Jacobsen et al.|JAMA|2019Cited by 141
Rationale and Design of an Adaptive Phase 2b/3 Clinical Trial of Selepressin for Adults in Septic Shock. Selepressin Evaluation Programme for Sepsis-induced Shock—Adaptive Clinical TrialRoger Lewis, Scott Berry, Derek C. Angus et al.|Annals of the American Thoracic Society|2018Cited by 44
Study protocol of a randomised, double-blind, placebo-controlled, two-arm parallel-group, multi-centre phase 3 pivotal trial to investigate the efficacy and safety of recombinant human alkaline phosphatase for treatment of patients with sepsis-associated acute kidney injuryPeter Pickkers, Anne Louise Kjølbye, Derek C. Angus et al.|BMJ Open|2023Cited by 17